👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Australia battles fresh Omicron outbreak as COVID deaths rise

Published 07/21/2022, 12:12 AM
Updated 07/21/2022, 12:15 AM
© Reuters. FILE PHOTO: Customers queue outside a Western Sydney chemist to purchase Rapid Antigen Test kits in the wake of the coronavirus disease (COVID-19) pandemic in Sydney, Australia, January 5, 2022.  REUTERS/Jaimi Joy

SYDNEY (Reuters) - Australia reported one of its highest daily death tolls from the novel coronavirus on Thursday while hospital admissions hovered near record levels, as authorities struggle to get ahead of highly contagious Omicron variants.

The BA.4/5 variants are good at evading immune protection from vaccination or prior infection and have been driving a surge of new infections globally.

Australia is reporting the highest daily numbers since the first Omicron wave earlier this year, with 89 deaths from the coronavirus on Thursday and 90 on Wednesday. Just over 55,600 new cases were recorded on Thursday, the highest since May 18.

Prime Minister Anthony Albanese said state leaders and federal health officials have not recommended making masks mandatory in indoor venues, despite calls by some doctors to do so.

Australia avoided the high death tolls seen in other countries during the first waves of the pandemic thanks largely to high levels of public compliance with tough social distancing restrictions.

But there is little public appetite for a return to such measures to defeat the latest surge in infections and Albanese has resisted pressure from some health experts to impose mask mandates.

"It's no good having a mandate unless it's enforced," Albanese told ABC Radio.

He said health officials also had to take into account the effects of tough restrictions on mental health.

The latest Omicron wave is pushing the number of people with COVID-19 in Australian hospitals close to the peak hit in January. About 5,350 patients are in hospitals, and several states are battling record admissions.

© Reuters. FILE PHOTO: Customers queue outside a Western Sydney chemist to purchase Rapid Antigen Test kits in the wake of the coronavirus disease (COVID-19) pandemic in Sydney, Australia, January 5, 2022.  REUTERS/Jaimi Joy

Authorities have urged businesses to let staff work from home and recommended people get booster shots urgently, with only about 71% of the eligible population having received their boosters. About 95% of people above 16 have had two doses.

Since the pandemic began, Australia has reported about 9 million COVID-19 cases and 10,968 deaths.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.